Mitchell H. Gold M.D.
Net Worth

Last updated:

What is Mitchell H. Gold M.D. net worth?

The estimated net worth of Dr. Mitchell H. Gold M.D. is at least $14,591,458 as of 8 May 2024. He has earned $9,686,458 from insider trading and has received compensation worth at least $4,905,000 in Alpine Immune Sciences, Inc..

What is the salary of Mitchell H. Gold M.D.?

Dr. Mitchell H. Gold M.D. salary is $817,500 per year as Executive Chairman & Chief Executive Officer in Alpine Immune Sciences, Inc..

How old is Mitchell H. Gold M.D.?

Dr. Mitchell H. Gold M.D. is 57 years old, born in 1968.

What stocks does Mitchell H. Gold M.D. currently own?

As insider, Dr. Mitchell H. Gold M.D. owns shares in one company:

Company Title Shares Price per share Total value
Alpine Immune Sciences, Inc. (ALPN) Executive Chairman & Chief Executive Officer 32,450 $0 $0

What does Alpine Immune Sciences, Inc. do?

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

ALPN logo
ALPN
Alpine Immune Sciences, Inc.

Mitchell H. Gold M.D. insider trading

Alpine Immune Sciences, Inc.

Dr. Mitchell H. Gold M.D. has made 23 insider trades between 2019-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 445,262 units of ALPN stock on 17 Sep 2021. As of 8 May 2024 he still owns at least 32,450 units of ALPN stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to buy) 13,245 $7.55 $100,000
Option
Common Stock 13,245 $7.55 $100,000
Option
Common Stock 74,441 $12.74 $948,378
Option
Common Stock 1,016 $0.65 $660
Option
Stock Option (Right to buy) 1,016 $0.65 $660
Sale
Common Stock 1,016 $20.04 $20,362
Option
Warrant (right to buy) 74,441 $12.74 $948,378
Option
Stock Option (Right to buy) 29,573 $0.65 $19,222
Sale
Common Stock 29,573 $20.04 $592,732
Option
Common Stock 29,573 $0.65 $19,222
Sale
Common Stock 24,486 $20.23 $495,229
Option
Stock Option (Right to buy) 2,402 $0.45 $1,081
Option
Common Stock 2,402 $0.45 $1,081
Option
Common Stock 22,084 $0.65 $14,355
Option
Stock Option (Right to buy) 22,084 $0.65 $14,355
Sale
Common Stock 37,825 $20.43 $772,613
Option
Stock Option (Right to buy) 37,825 $0.45 $17,021
Option
Common Stock 37,825 $0.45 $17,021
Sale
Common Stock 2,402 $20.01 $48,064
Option
Common Stock 2,402 $0.45 $1,081
Option
Stock Option (Right to buy) 2,402 $0.45 $1,081
Sale
Common Stock 8,613 $17.32 $149,143
Option
Stock Option (Right to buy) 8,613 $0.45 $3,876
Option
Common Stock 8,613 $0.45 $3,876
Sale
Common Stock 68,870 $17.27 $1,189,041
Sale
Common Stock 8,067 $17.08 $137,784
Sale
Common Stock 445,262 $9.7 $4,320,822
Sale
Common Stock 6,768 $10 $67,694
Sale
Common Stock 3,484 $10 $34,840
Sale
Common Stock 3,479 $10 $34,793
Sale
Common Stock 9,473 $10.01 $94,863
Sale
Common Stock 1,221 $15 $18,316
Sale
Common Stock 50,965 $15.03 $765,902
Sale
Common Stock 10,000 $11.52 $115,170
Sale
Common Stock 10,000 $11.52 $115,170
Sale
Common Stock 10,000 $10.52 $105,200
Sale
Common Stock 10,000 $10.52 $105,200
Sale
Common Stock 10,000 $12.99 $129,880
Sale
Common Stock 10,000 $12.99 $129,880
Sale
Common Stock 10,000 $11.74 $117,380
Sale
Common Stock 10,000 $12.64 $126,380
Purchase
Common Stock 190,875 N/A N/A
Purchase
Warrant (right to buy) 74,441 $12.74 $948,378

Alpine Immune Sciences key executives

Alpine Immune Sciences, Inc. executives and other stock owners filed with the SEC: